Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)
5.59
-0.11 (-1.93%)
May 20, 2026, 1:55 PM CST
SHE:300158 Revenue
Shanxi Zhendong Pharmaceutical Co.,Ltd had revenue of 649.13M CNY in the quarter ending March 31, 2026, a decrease of -13.97%. This brings the company's revenue in the last twelve months to 2.68B, down -9.03% year-over-year. In the year 2025, Shanxi Zhendong Pharmaceutical Co.,Ltd had annual revenue of 2.78B, down -6.33%.
Revenue (ttm)
2.68B
Revenue Growth
-9.03%
P/S Ratio
2.11
Revenue / Employee
724.67K
Employees
3,695
Market Cap
5.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.78B | -188.07M | -6.33% |
| Dec 31, 2024 | 2.97B | -654.89M | -18.06% |
| Dec 31, 2023 | 3.63B | -102.54M | -2.75% |
| Jan 1, 2023 | 3.73B | -1.37B | -26.80% |
| Jan 1, 2022 | 5.09B | 245.94M | 5.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 25.24B |
| HPGC Renmintongtai Pharmaceutical | 10.54B |
| Jiangsu Lianhuan Pharmaceutical | 2.89B |
| Luoxin Pharmaceuticals Group Stock | 2.37B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.68B |
| Shanghai Kaibao Pharmaceutical CO.,Ltd | 1.04B |
| Jiangsu Jibeier Pharmaceutical | 990.68M |
| ChengDu ShengNuo Biotec | 801.40M |